iPath Inverse S&P 500 VIX Short-Term Futures
IVOP
IVOP was delisted on the 23rd of March, 2018.
1 hedge funds and large institutions have $0 invested in iPath Inverse S&P 500 VIX Short-Term Futures in 2017 Q4 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
50% less funds holding
Funds holding: 2 → 1 (-1)
100% less capital invested
Capital invested by funds: $350K → $0 (-$350K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$350K |
IVOP Hedge Fund Activity: Q4 2017 in Review
1 of the 4,410 institutional investors tracked by Wall St. Rank reported a position in iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) for Q4 2017, worth a combined $0 — down 100% from $350K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of IVOP and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Virtu Financial, exiting entirely with an estimated $350K sold.
- 1 institutional investor held iPath Inverse S&P 500 VIX Short-Term Futures (IVOP) as of Q4 2017, down from 2 in Q3 2017.
- Funds reported $0 of iPath Inverse S&P 500 VIX Short-Term Futures stock for Q4 2017, down 100% quarter-over-quarter.
- 0 funds opened new iPath Inverse S&P 500 VIX Short-Term Futures positions in Q4 2017 and 1 closed out, a net change of -1 holder.
- The largest iPath Inverse S&P 500 VIX Short-Term Futures seller in Q4 2017 was Virtu Financial, an estimated $350K sold.
Based on aggregated 13F filings for Q4 2017.